Related Experiment Video
Updated: Aug 15, 2026

06:51
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Toxigenic C. difficile induced inflammatory marker expression by human intestinal epithelial cells is asymmetrical
Geraldine Canny1, Denise Drudy, Padraic Macmathuna
1Department of Veterinary Physiology and Biochemistry, Faculty of Veterinary Medicine, University College Dublin, Belfield Campus, Dublin 4, Ireland.
Life Sciences
|September 28, 2005
Summary
Clostridium difficile infection triggers inflammation by upregulating IL-8 and ICAM-1. Bacterial entry into the intestinal epithelium
Area of Science:
- Microbiology
- Immunology
- Gastroenterology
Background:
- Clostridium difficile infection (CDI) causes significant morbidity and mortality, primarily attributed to toxin production.
- The precise mechanisms initiating CDI pathogenesis, particularly epithelial responses, require further elucidation.
Purpose of the Study:
- To investigate the role of toxigenic C. difficile in modulating human intestinal epithelial cell responses.
- To determine the involvement of specific inflammatory mediators, IL-8 and ICAM-1, in CDI pathogenesis.
Main Methods:
- Utilized in vitro models of human intestinal epithelial layers.
- Exposed epithelial layers to toxigenic C. difficile and toxin-containing supernatants.
- Assessed the expression of IL-8 and ICAM-1, and measured transepithelial electrical resistance.
Main Results:
- Toxigenic C. difficile upregulated epithelial IL-8 and ICAM-1 expression.
- IL-8 production was stimulated by both bacteria and their toxins, and inhibited by antiserum.
- ICAM-1 upregulation required basolateral exposure, while apical exposure impaired epithelial integrity.
- Apical exposure to C. difficile compromised transepithelial electrical resistance, suggesting barrier disruption.
Conclusions:
- C. difficile infection initiates inflammatory responses through upregulation of IL-8 and ICAM-1.
- Epithelial barrier disruption by apical bacterial exposure facilitates basolateral access, activating inflammatory pathways.
- These findings suggest a model where initial epithelial damage precedes full inflammatory activation in CDI.
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Dysbiosis of the Gut Microbiota
The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Inflammatory Bowel Disease II: Crohn's Disease
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
